idiopathic hypersomnia/fatigue

Lyen an sove nan clipboard la

Chwazi kalite sòt

7 rezilta yo

Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To characterize the clinical, psychological, and sleep pattern of idiopathic hypersomnia with and without long sleep time, and provide normative values for 24-hour polysomnography. METHODS University Hospital. METHODS Controlled, prospective cohort. METHODS 75 consecutive patients (aged 34

How significant are primary sleep disorders and sleepiness in the chronic fatigue syndrome?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In order to study both the prevalence of Primary Sleep Disorders (PSD) and sleepiness, and their association to the Chronic Fatigue Syndrome (CFS), 46 unselected outpatients (34 women, mean age 36.5) were examined clinically and underwent two nights of all-night polysomnography and multiple sleep

Systemic exertion intolerance disease/chronic fatigue syndrome is common in sleep centre patients with hypersomnolence: A retrospective pilot study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Symptoms of the central disorders of hypersomnolence extend beyond excessive daytime sleepiness to include non-restorative sleep, fatigue and cognitive dysfunction. They share much in common with myalgic encephalomyelitis/chronic fatigue syndrome, recently renamed systemic exertion intolerance

Modafinil: the unique properties of a new stimulant.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Modafinil, a novel stimulant which has several remarkable features that distinguish it from other stimulants, has been developed by Lafon, a French pharmaceutical company. Unlike the amphetamines, for example, modafinil is reported to have minimal peripheral side effects at therapeutic doses. It

[Narcolepsy and Other 'Central Disorders of Hypersomnolence'].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Narcolepsy and Other 'Central Disorders of Hypersomnolence' Abstract. 'Excessive daytime sleepiness', 'hypersomnia' in the sense of prolonged sleep need, 'tiredness' or 'fatigue' are frequent complaints in primary care, requiring a careful separation in view of a correct diagnostic. After exclusion

The Perception and Attention Functions test battery as a measure of neurocognitive impairment in patients with suspected central disorders of hypersomnolence.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The aim of the current study was to evaluate an attention test as a discriminative tool to measure neurocognitive impairment in patients with disorders of hypersomnolence. Chronic excessive daytime sleepiness is the main symptom in central disorders of hypersomnolence. For diagnostic purposes and

Relationship of rare disorder latent clusters to anxiety and depression symptoms.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A single rare disorder or disease (RD) affects fewer than 200,000 Americans. Combined, RDs affect 30 million Americans. Collectively, people with RDs have higher levels of anxiety and depression compared with those with prevalent diseases. Previous attempts to study psychological

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye